The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly
Open accessAbstract
BACKGROUND: As compared with what is known about predictors of vascular events in middle-aged persons, less is known about these events in the elderly. Lp(a) lipoprotein, which plays an important part in atherothrombogenesis, has been associated with an increased risk of vascular disease. We investigated this relation among older U.S. adults. METHODS: In a prospective study of 5888 community-dwelling older adults (65 years of age or older) in the United States, 2375 women and 1597 men who were free of vascular disease provided base-line serum samples for analysis for levels of Lp(a) lipoprotein. These 3972 subjects were followed for a median of 7.4 years to evaluate the development of stroke and to track deaths from vascular causes and all causes. The men and women were divided into quintile groups according to the Lp(a) lipoprotein level at base line. RESULTS: Using Cox proportional-hazards models, we determined the risk associated with each quintile level of Lp(a) lipoprotein, with the lowest quintile serving as the reference group. As compared with those in the lowest quintile, men in the highest quintile had three times the unadjusted risk of stroke (relative risk, 3.00; 95 percent confidence interval, 1.59 to 5.65), almost three times the risk of death associated with vascular events (relative risk, 2.54; 95 percent confidence interval, 1.59 to 4.08), and nearly twice the risk of death from all causes (relative risk, 1.76; 95 percent confidence interval, 1.31 to 2.36). Adjustment for age; sex; the levels of total cholesterol, low-density lipoprotein cholesterol, and triglycerides; carotid-wall thickness; smoking status; the presence or absence of diabetes and systolic and diastolic hypertension; body-mass index; and other traditional risk factors had little effect on the final assessments. Similar analyses for women, which also included adjustment for estrogen use or nonuse, revealed no such relation. CONCLUSIONS: Among older adults in the United States, an elevated level of Lp(a) lipoprotein is an independent predictor of stroke, death from vascular disease, and death from any cause in men but not in women. These data support the use of Lp(a) lipoprotein levels in predicting the risk of these events in older men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Self-citationSurveillance and ascertainment of cardiovascular events
Ives, D. G., Fitzpatrick, A. L., Bild, D. E., Psaty, B. M., Kuller, L. H., Crowley, P. M., Cruise, R. G., & Theroux, S. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00093-9 · Cited by 688
Recruitment of adults 65 years and older as participants in the cardiovascular health study
Tell, G. S., Fried, L. P., Hermanson, B., Manolio, T. A., Newman, A. B., & Borhani, N. O. (1993) · Annals of Epidemiology · doi:10.1016/1047-2797(93)90062-9 · Cited by 556
A Prospective Study of Lipoprotein(a) and the Risk of Myocardial Infarction
Ridker, P. M. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510180065035 · Cited by 512
Schaefer, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510370051031 · Cited by 487
Human plasma lipoprotein [a]. Structural properties.
Gaubatz, J. W., Heideman, C., Gotto, A. M., Morrisett, J. D., & Dahlen, G. H. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32663-2 · Cited by 453
Assmann, G., Schulte, H., & von Eckardstein, A. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00159-2 · Cited by 447
Bostom, A. G. (1996) · JAMA · doi:10.1001/jama.1996.03540070040028 · Cited by 398
Lipoprotein(a) as a strong indicator for cerebrovascular disease.
Zenker, G., Költringer, P., Boné, G., Niederkorn, K., Pfeiffer, K., & Jürgens, G. (1986) · Stroke · doi:10.1161/01.str.17.5.942 · Cited by 329
Lipoprotein(a). A unique risk factor for atherothrombotic disease.
Loscalzo, J. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.5.672 · Cited by 296
Bostom, A. G., Gagnon, D. R., Cupples, L. A., Wilson, P. W., Jenner, J. L., Ordovas, J. M., Schaefer, E. J., & Castelli, W. P. (1994) · Circulation · doi:10.1161/01.cir.90.4.1688 · Cited by 255
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies
Craig, W. Y., Neveux, L. M., Palomaki, G. E., Cleveland, M. M., & Haddow, J. E. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.11.2301 · Cited by 210
Lipoprotein(a) as a strong indicator for cerebrovascular disease.
GZenker, PKöltringer, GBoné, et al. (1986) · Stroke · Cited by 197
Wild, S. H., Fortmann, S. P., & Marcovina, S. M. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.2.239 · Cited by 194
Cantin, B., Gagnon, F., Moorjani, S., Després, J., Lamarche, B., Lupien, P. J., & Dagenais, G. R. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00528-7 · Cited by 152
Dangas, G., Mehran, R., Harpel, P. C., Sharma, S. K., Marcovina, S. M., Dube, G. K., Ambrose, J. A., & Fallon, J. T. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00469-0 · Cited by 144
Plasma Concentration of Lipoprotein(a) and the Risk of Future Stroke
Ridker, P. M. (1995) · JAMA · doi:10.1001/jama.1995.03520400039041 · Cited by 141
Nguyen, T. T., Ellefson, R. D., Hodge, D. O., Bailey, K. R., Kottke, T. E., & Abu-Lebdeh, H. S. (1997) · Circulation · doi:10.1161/01.cir.96.5.1390 · Cited by 133
High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction.
Shintani, S., Kikuchi, S., Hamaguchi, H., et al. (1993) · Stroke · doi:10.1161/01.str.24.7.965 · Cited by 116
Kario, K., Matsuo, T., Kobayashi, H., Asada, R., & Matsuo, M. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.6.734 · Cited by 111
Schaefer, E. J. (1994) · JAMA · doi:10.1001/jama.271.13.999 · Cited by 96
Bostom, A. G. (1996) · JAMA · doi:10.1001/jama.276.7.544 · Cited by 83
Cambillau, M., Simon, A. C., Amar, J., Giral, P., Atger, V., Segond, P., Levenson, J. A., Merli, I. P., Mégnien, J. L., & Plainfosse, M. C. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1346 · Cited by 81
Apolipoprotein(a) isoforms and coronary heart disease in men
Klausen, I. C., Sjøl, A., HANSEN, P. S., Gerdes, L. U., Møller, L. F., Lemming, L., Schroll, M., & Færgeman, O. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00071-3 · Cited by 77
Does Lipoprotein(a) Impair Endothelial Function?
Schlaich, M. P., John, S., Langenfeld, M. R. W., Lackner, K. J., Schmitz, G., & Schmieder, R. E. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00497-x · Cited by 71
A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women
Coleman, M. P., Key, T. J. A., Wang, D. Y., Hermon, C., Fentiman, I. S., Allen, D., Jarvis, M. J., Pike, M. C., & Sanders, T. A. B. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90276-m · Cited by 63
Coronary heart disease in the elderly.
Rf, G., & Feinleib, M. (1988) · PubMed · Cited by 63
Sunayama, S., Daida, H., Mokuno, H., Miyano, H., Yokoi, H., Lee, Y. J., Sakurai, H., & Yamaguchi, H. (1996) · Circulation · doi:10.1161/01.cir.94.6.1263 · Cited by 56
A monoclonal-antibody-based enzyme-linked immunosorbent assay of lipoprotein(a)
Wong, W. L., Eaton, D., Berloui, A., FENDLY, B. M., & Hass, P. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.2.192 · Cited by 47
Kario, K., Matsuo, T., Imiya, M., et al. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90179-1 · Cited by 36
Dahlén, Weinehall, Weinehall, Stenlund, Jansson, Hallmans, Huhtasaari, & Wall (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00422.x · Cited by 35
Lipoprotein (a), Lipids, Aspirin, and Risk of Myocardial Infarction in the Physician's Health Study
Ariyo, A., Hennekens, C. H., Stampfer, M. J., & Ridker, P. M. (1998) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679800500410 · Cited by 19
Self-citation
Cited by
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,368
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Kamstrup, P. R. (2009) · JAMA · doi:10.1001/jama.2009.801 · Cited by 1,357
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Metadata
- Authors
- Ariyo, A. A., Thach, C., & Tracy, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-11-27
- Volume
- 349
- Issue
- 22
- Pages
- 2108-2115
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1975678175
- Cited by
- 288
- References
- 34
- FWCI
- 23.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.